The law offices of frank r. cruz announces investigation of brainstorm cell therapeutics inc. (bcli) on behalf of investors

Los angeles--(business wire)--the law offices of frank r. cruz announces an investigation of brainstorm cell therapeutics inc. (“brainstorm cell” or the “company”) (nasdaq: bcli) on behalf of investors concerning the company's possible violations of federal securities laws. if you are a shareholder who suffered a loss, click here to participate. on november 10, 2022, brainstorm cell disclosed that the u.s. food and drug administration (“fda”) had rejected its new biologics license application (.
BCLI Ratings Summary
BCLI Quant Ranking